JAMA : the journal of the American Medical Association
-
There is a major need for effective, well-tolerated treatments for idiopathic pulmonary fibrosis (IPF). ⋯ Ziritaxestat did not improve clinical outcomes compared with placebo in patients with IPF receiving standard of care treatment with pirfenidone or nintedanib or in those not receiving standard of care treatment.
-
Comment Letter Comparative Study
High-Flow Nasal Oxygen vs Standard Oxygen Therapy and Length of Hospital Stay in Children With Acute Hypoxemic Respiratory Failure.